Although topical STA-9090 treatment elicited neither skin irritation nor signs of systemic toxicity such as weight loss or death in mice with AD, long-term safety studies of topical Hsp90 inhibitors are still needed. Here, HSP90AA1 is linked to Alzheimer disease.